Sims Karen has filed 7 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 49300 shares of Arbutus Biopharma Corp ($ABUS) on February 14, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | Arbutus Biopharma Corp | $ABUS | Sims Karen | Chief Medical Officer | A | Common Shares | 49300 | $0.00 | 155,494.0000 | 0 | 46.42% | 0.00% |
| Feb. 14, 2025 | Arbutus Biopharma Corp | $ABUS | Sims Karen | Chief Medical Officer | A | Stock Option (Right to Buy) | 200300 | $0.00 | 200,300.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2025 | Arbutus Biopharma Corp | $ABUS | Sims Karen | Chief Medical Officer | S | Common Shares | 19348 | $3.28 | 106,194.0000 | 0 | 15.41% | 0.00% |
| Feb. 1, 2024 | Arbutus Biopharma Corp | $ABUS | Sims Karen | Chief Medical Officer | A | Common Shares | 101000 | $0.00 | 129,900.0000 | 0 | 349.48% | 0.00% |
| Feb. 2, 2024 | Arbutus Biopharma Corp | $ABUS | Sims Karen | Chief Medical Officer | S | Common Shares | 4358 | $2.31 | 125,542.0000 | 0 | 3.35% | 0.00% |
| Feb. 1, 2024 | Arbutus Biopharma Corp | $ABUS | Sims Karen | Chief Medical Officer | A | Stock Option (Right to Buy) | 403900 | $0.00 | 403,900.0000 | 0 | 9999.99% | 0.00% |
| July 10, 2023 | Arbutus Biopharma Corp | $ABUS | Sims Karen | Chief Medical Officer | A | Stock Option (Right to Buy) | 153640 | $0.00 | 153,640.0000 | 0 | 9999.99% | 0.00% |